Patents by Inventor Peter Fuhge

Peter Fuhge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6500427
    Abstract: A description is given of a one-component tissue adhesive containing, in aqueous solution, fibrinogen, F XIII, a thrombin inhibitor, prothrombin factors, calcium ions and, where appropriate, a plasmin inhibitor and of a process for the production thereof. This adhesive can be reconstituted from a freeze-dried form with water. It can contain aLL active substances in pasteurized form and is then free of the risk of transmission of hepatitis and HTLV III.
    Type: Grant
    Filed: October 20, 1994
    Date of Patent: December 31, 2002
    Assignee: Aventis Behring GmbH
    Inventors: Norbert Heimburger, Peter Fuhge, Hansjörg Ronneberger
  • Patent number: 5407671
    Abstract: A description is given of a one-component tissue adhesive containing, in aqueous solution, fibrinogen, F XIII, a thrombin inhibitor, prothrombin factors, calcium ions and, where appropriate, a plasmin inhibitor and of a process for the production thereof.This adhesive can be reconstituted from a freeze-dried form with water. It can contain all active substances in pasteurized form and is then free of the risk of transmission of hepatitis and HTLV III.
    Type: Grant
    Filed: November 30, 1992
    Date of Patent: April 18, 1995
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Norbert Heimburger, Peter Fuhge, Hansjorg Ronneberger
  • Patent number: 4960757
    Abstract: A pasteurized human firbinogen which can be used therapeutically, and a process for its preparation are described.
    Type: Grant
    Filed: August 1, 1988
    Date of Patent: October 2, 1990
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Gerhardt Kumpe, Wilfried Wormsbacher, Norbert Heimburger, Peter Fuhge, Hans M. Preis
  • Patent number: 4650678
    Abstract: A solid fibrinogen formulation is described, which formulation contains, in addition to fibrinogen, a substance containing the urea or guanidine radical, and a process for its preparation. This formulation is used for the preparation of a fibrinogen solution which is suitable as an adhesive for human and animal tissue and as a fibrinogen concentrate for intravenous administration.
    Type: Grant
    Filed: August 10, 1984
    Date of Patent: March 17, 1987
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Peter Fuhge, Norbert Heimburger, Hans-Arnold Stohr, Wolfgang Burk
  • Patent number: 4621631
    Abstract: A process for the production of an unnative and biologically active bonded collagen fiber sheet from human placentae is described, in which process collagen-containing material from placentae is treated with a neutral salt solution, a solution of citric acid and with pepsin. The degraded collagen material obtained in this manner is, where appropriate, treated with a crosslinking agent. The collagen material produced in this manner is used for producing bonded collagen fiber sheets which can be used, for example, as covering for wounds.
    Type: Grant
    Filed: December 23, 1983
    Date of Patent: November 11, 1986
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Eric P. Paques, Peter Fuhge
  • Patent number: 4510126
    Abstract: An agent for determining ristocetin cofactor (v.Willebrand factor) is described, which contains platelets which have been treated with a tanning agent, with a protease inhibitor and, optionally, with a dye-stuff, and ristocetin A.
    Type: Grant
    Filed: September 30, 1982
    Date of Patent: April 9, 1985
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Peter Fuhge, Konrad Braun, Udo Becker